oxybutynin has been researched along with Neural Tube Defects in 4 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Neural Tube Defects: Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy generally occurring between days 18-29 of gestation. Ectodermal and mesodermal malformations (mainly involving the skull and vertebrae) may occur as a result of defects of neural tube closure. (From Joynt, Clinical Neurology, 1992, Ch55, pp31-41)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, M | 1 |
| Kang, JY | 1 |
| Jeong, J | 1 |
| Kim, DK | 1 |
| Kim, KM | 1 |
| Painter, KA | 1 |
| Vates, TS | 1 |
| Bukowski, TP | 1 |
| Fleming, P | 1 |
| Freedman, AL | 1 |
| Smith, CA | 1 |
| Gonzalez, R | 1 |
| Perlmutter, AD | 1 |
| Amark, P | 1 |
| Bussman, G | 1 |
| Eksborg, S | 1 |
| Kasabian, NG | 1 |
| Bauer, SB | 1 |
| Dyro, FM | 1 |
| Colodny, AH | 1 |
| Mandell, J | 1 |
| Retik, AB | 1 |
1 trial available for oxybutynin and Neural Tube Defects
| Article | Year |
|---|---|
Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children.
Topics: Administration, Intravesical; Adolescent; Child; Child, Preschool; Cholinergic Antagonists; Female; | 1998 |
3 other studies available for oxybutynin and Neural Tube Defects
| Article | Year |
|---|---|
Treatment outcomes according to neuropathic bladder sphincter dysfunction type after treatment of oxybutynin chloride in children with myelodysplasia.
Topics: Administration, Oral; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Mus | 2013 |
Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia.
Topics: Administration, Intravesical; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Male; Man | 1996 |
The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration.
Topics: Boston; Combined Modality Therapy; Female; Follow-Up Studies; Hospitals, Pediatric; Humans; Hydronep | 1992 |